Biologics Market Research Report, Growth & Forecast

According to our (Global Info Research) latest study, the global Lentivirus Particle market size was valued at US$ 322 million in 2025 and is forecast to a readjusted size of US$ 428 million by 2032 w...

According to our (Global Info Research) latest study, the global Depth Filtration in Biologics Manufacturing market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ m...

According to our (Global Info Research) latest study, the global Gene Therapy Viral Vector and Plasmid DNA market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ mil...

According to our (Global Info Research) latest study, the global Depth Filter Sheets in Biologics Manufacturing market size was valued at US$ 61.29 million in 2025 and is forecast to a readjusted size...

According to our (Global Info Research) latest study, the global Depth Filter Capsules for Biopharmaceutical market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ m...

According to our (Global Info Research) latest study, the global High Throughput Antibody Production Services market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$...

According to our (Global Info Research) latest study, the global Lentiviral Packaging Services market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032...

According to Stratistics MRC, the Global Erythropoietin Drugs Market is accounted for $15.5 billion in 2026 and is expected to reach $41.8 billion by 2034 growing at a CAGR of 13.2% during the forecas...

Hepatitis C interferons are a group of biological therapeutic drugs with antiviral and immunomodulatory effects, which are mainly used for the treatment of chronic hepatitis C virus infection. By acti...

According to our (Global Info Research) latest study, the global Engineered Cell Therapy market size was valued at US$ 6288 million in 2025 and is forecast to a readjusted size of US$ 15270 million by...

The global AAV Characterization Services market size is predicted to grow from US$ 710 million in 2025 to US$ 1731 million in 2032; it is expected to grow at a CAGR of 13.6% from 2026 to 2032. AAV Cha...

The global Anti-IL4RA Antibody Products market size is predicted to grow from US$ 16014 million in 2025 to US$ 33109 million in 2032; it is expected to grow at a CAGR of 11.1% from 2026 to 2032. In 20...

The global Lipid Nanoparticle (LNP) Encapsulation Services market size is predicted to grow from US$ 712 million in 2025 to US$ 1469 million in 2032; it is expected to grow at a CAGR of 10.9% from 202...

The global Recombinant Human Anti-IL-4R? Monoclonal Antibody market size is predicted to grow from US$ 15054 million in 2025 to US$ 31367 million in 2032; it is expected to grow at a CAGR of 11.2% fro...

Dupixent Market The global dupixent market size was estimated at USD 15,237.40 million in 2025 and is projected to reach USD 27,582.67 million by 2033, growing at a CAGR of 7.70% from 2026 to 2033. Th...

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommend...

According to our (Global Info Research) latest study, the global Closed Cell Processing Systems for Cell Therapy market size was valued at US$ million in 2025 and is forecast to a readjusted size of U...

Interferons are a group of signaling proteins made and released by host cells in response to the presence of several viruses. In a typical scenario, a virus-infected cell will release interferons caus...

Interferons are a group of signaling proteins made and released by host cells in response to the presence of several viruses. In a typical scenario, a virus-infected cell will release interferons caus...

Elocta is a medicine used to treat and prevent bleeding in patients with haemophilia A (an inherited bleeding disorder caused by lack of factor VIII).The Elocta and Eloctate market is primarily driven...

ELOCTATE, a therapy regimen for the treatment of hemophilia A that uses Fc Fusion to keep Factor VIII circulating in your bloodstream longer.Eloctate is a recombinant clotting factor VIII therapy used...

A tumor necrosis factor (TNF)-? inhibitorThe global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical dr...

Interferon beta-1a is in a class of medications called immunomodulators. It works by decreasing inflammation and preventing nerve damage that may cause symptoms of multiple sclerosis.Interferon Beta-1...

Abatacept (marketed as Orencia) is a drug used to treat autoimmune diseases like rheumatoid arthritis, by interfering with the immune activity of T cells. It is a modified antibody.The global pharmace...

Stelara is the brand name for ustekinumab, which is a medication used to treat certain immune-mediated inflammatory conditions. It is primarily used for the treatment of psoriasis and psoriatic arthri...

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spen...

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommend...

Interferons (IFNs) are a group of signaling proteins made and released by host cells in response to the presence of several pathogens, such as viruses, bacteria, parasites, and also tumor cells. In a...

Interferons (IFNs) are a group of signaling proteins made and released by host cells in response to the presence of several pathogens, such as viruses, bacteria, parasites, and also tumor cells. In a...

According to Stratistics MRC, the Regenerative Medicine Market is estimated at $20.07 billion in 2015 and is projected to reach $101.3 billion by 2022 ... for regenerative medicine market. Europe and North America together accounted for over 3/4th of the market revenue and anticipated to be most profitable regional market. Some ...

... five years the Biologics and Biosimilars market will register a 4.5% CAGR in terms of revenue, the global market size will reach ... understand the structure of Biologics and Biosimilars market by identifying its various subsegments. Focuses on the key global Biologics and Biosimilars manufacturers, to define, ...

The global Peptide Therapeutics market size is predicted to grow from US$ 43350 million in 2025 to US$ 80060 million in 2032; it is expected to grow at a CAGR of 9.3% from 2026 to 2032. Peptide therap...

The global Lipid Nanoparticle CDMO market size is predicted to grow from US$ 726 million in 2025 to US$ 1130 million in 2032; it is expected to grow at a CAGR of 6.5% from 2026 to 2032. Lipid Nanopart...

According to Stratistics MRC, the Global Biopharmaceuticals Market is accounted for $607.0 billion in 2026 and is expected to reach $1330.0 billion by 2034 growing at a CAGR of 10.3% during the foreca...

According to Stratistics MRC, the Global Biosimilars Market is accounted for $46.6 billion in 2026 and is expected to reach $146.5 billion by 2034 growing at a CAGR of 15.4% during the forecast period...

The global Immune Intervention market size is predicted to grow from US$ 258551 million in 2025 to US$ 392650 million in 2032; it is expected to grow at a CAGR of 6.1% from 2026 to 2032. Immune interv...

The global Immunotherapy Products market size is predicted to grow from US$ 258551 million in 2025 to US$ 392650 million in 2032; it is expected to grow at a CAGR of 6.1% from 2026 to 2032. Immunother...

Cytokine-based Therapeutics Marketis is growing with a CAGR of 10.80% during the forecast period 2026-2035. The Cytokine-based Therapeutics Market emerges as a key focus in DataM Intelligence latest i...

Advanced Therapy Medicinal Product (ATMP) Market reached USD 43.09 billion in 2025 and is expected to reach USD 149.24 billion by 2033, growing with a CAGR of 16.80% during the forecast period 2026-20...

The Global Plasma Fractionation Market is anticipated to expand from USD 26.81 Billion in 2025 to USD 39.01 Billion by 2031, reflecting a compound annual growth rate of 6.45%. This complex procedure i...

The Global market for mesenchymal stem cells is expected to expand from USD 2.98 billion in 2025 to USD 4.95 billion by 2031, reflecting a compound annual growth rate of 8.83%. Mesenchymal stem cells...

The Global market for next-generation biotherapeutics is anticipated to expand from USD 5.71 billion in 2025 to USD 11.65 billion by 2031, reflecting a compound annual growth rate of 12.62%. These adv...

The global Cell and Gene Therapy market size is predicted to grow from US$ 3502 million in 2025 to US$ 5670 million in 2032; it is expected to grow at a CAGR of 7.1% from 2026 to 2032. Cell and Gene T...

The global Cellular and Gene Therapy CDMO market size is predicted to grow from US$ 3972 million in 2025 to US$ 6432 million in 2032; it is expected to grow at a CAGR of 7.1% from 2026 to 2032. A Cell...

The global Cell Therapy CMO market size is predicted to grow from US$ 2827 million in 2025 to US$ 4617 million in 2032; it is expected to grow at a CAGR of 7.2% from 2026 to 2032. Cell Therapy CMO is...

The global Cell and Gene Therapy CDMO market size is predicted to grow from US$ 3972 million in 2025 to US$ 6432 million in 2032; it is expected to grow at a CAGR of 7.1% from 2026 to 2032. Cell and G...

The global Cell and Gene Therapy Supply Chain and Logistics market size is predicted to grow from US$ 6408 million in 2025 to US$ 10527 million in 2032; it is expected to grow at a CAGR of 7.1% from 2...

The global Anti-IL-4R? Antibody market size is predicted to grow from US$ 17309 million in 2025 to US$ 37171 million in 2032; it is expected to grow at a CAGR of 11.8% from 2026 to 2032. In 2025, glob...

The global Human Anti-IL-4R? Monoclonal Antibody market size is predicted to grow from US$ 16014 million in 2025 to US$ 33109 million in 2032; it is expected to grow at a CAGR of 11.1% from 2026 to 20...

According to Stratistics MRC, the Global Biologics Outsourcing Market is accounted for $37.1 billion in 2026 and is expected to reach $121.7 billion by 2034 growing at a CAGR of 16.0% during the forec...